1 |
Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008;118:3546-3556.
DOI
ScienceOn
|
2 |
Wills-Karp M, Finkelman FD. Untangling the complex web of IL-4- and IL-13-mediated signaling pathways. Sci Signal 2008;1:pe55.
DOI
ScienceOn
|
3 |
Smith WL, Meade EA, DeWitt DL. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2. Ann N Y Acad Sci 1994;714:136-142.
DOI
ScienceOn
|
4 |
Fujitani Y, Kanaoka Y, Aritake K, Uodome N, Okazaki-Hatake K, Urade Y. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J Immunol 2002;168:443-449.
DOI
|
5 |
Mandal AK, Zhang Z, Ray R, et al. Uteroglobin represses allergeninduced inflammatory response by blocking PGD2 receptormediated functions. J Exp Med 2004;199:1317-1330.
DOI
ScienceOn
|
6 |
Honda K, Arima M, Cheng G, et al. Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. J Exp Med 2003;198:533-543.
DOI
ScienceOn
|
7 |
Urade Y, Ujihara M, Horiguchi Y, Ikai K, Hayaishi O. The major source of endogenous prostaglandin D2 production is likely antigen- presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. J Immunol 1989;143:2982-2989.
|
8 |
Tanaka K, Ogawa K, Sugamura K, Nakamura M, Takano S, Nagata K. Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets. J Immunol 2000;164:2277-2280.
DOI
|
9 |
Murray JJ, Tonnel AB, Brash AR, et al. Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med 1986;315:800-804.
DOI
ScienceOn
|
10 |
Naclerio RM, Meier HL, Kagey-Sobotka A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128:597-602.
|
11 |
Charlesworth EN, Kagey-Sobotka A, Schleimer RP, Norman PS, Lichtenstein LM. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J Immunol 1991;146:671-676.
|
12 |
Benyon RC, Robinson C, Church MK. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br J Pharmacol 1989;97:898-904.
DOI
ScienceOn
|
13 |
Schulman ES, Newball HH, Demers LM, Fitzpatrick FA, Adkinson NF Jr. Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. Am Rev Respir Dis 1981;124:402-406.
|
14 |
Hirata M, Kakizuka A, Aizawa M, Ushikubi F, Narumiya S. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc Natl Acad Sci U S A 1994;91:11192-11196.
DOI
ScienceOn
|
15 |
Boie Y, Sawyer N, Slipetz DM, Metters KM, Abramovitz M. Molecular cloning and characterization of the human prostanoid DP receptor. J Biol Chem 1995;270:18910-18916.
DOI
ScienceOn
|
16 |
Hirai H, Tanaka K, Yoshie O, et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001;193:255-261.
DOI
ScienceOn
|
17 |
Sawyer N, Cauchon E, Chateauneuf A, et al. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br J Pharmacol 2002;137:1163-1172.
DOI
ScienceOn
|
18 |
Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001;108:15-23.
DOI
|
19 |
Giles H, Leff P, Bolofo ML, Kelly MG, Robertson AD. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Br J Pharmacol 1989;96:291-300.
DOI
ScienceOn
|
20 |
Whittle BJ, Hamid S, Lidbury P, Rosam AC. Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets. Adv Exp Med Biol 1985;192:109-125.
|
21 |
Gervais FG, Cruz RP, Chateauneuf A, et al. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J Allergy Clin Immunol 2001;108:982-988.
DOI
ScienceOn
|
22 |
Monneret G, Gravel S, Diamond M, Rokach J, Powell WS. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 2001;98:1942-1948.
DOI
ScienceOn
|
23 |
Angeli V, Staumont D, Charbonnier AS, et al. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J Immunol 2004;172:3822-3829.
DOI
|
24 |
Yoshimura-Uchiyama C, Iikura M, Yamaguchi M, et al. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptorhomologous molecule expressed on Th2 cells/DP2. Clin Exp Allergy 2004;34:1283-1290.
DOI
ScienceOn
|
25 |
Hammad H, de Heer HJ, Soullie T, Hoogsteden HC, Trottein F, Lambrecht BN. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. J Immunol 2003;171:3936-3940.
DOI
|
26 |
Hirano Y, Shichijo M, Deguchi M, et al. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells. Eur J Pharmacol 2007;560:81-88.
DOI
ScienceOn
|
27 |
Faveeuw C, Gosset P, Bureau F, et al. Prostaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways. Eur J Immunol 2003;33:889-898.
DOI
ScienceOn
|
28 |
Gosset P, Pichavant M, Faveeuw C, Bureau F, Tonnel AB, Trottein F. Prostaglandin D2 affects the differentiation and functions of human dendritic cells: impact on the T cell response. Eur J Immunol 2005;35:1491-1500.
DOI
ScienceOn
|
29 |
Tanaka K, Hirai H, Takano S, Nakamura M, Nagata K. Effects of prostaglandin D2 on helper T cell functions. Biochem Biophys Res Commun 2004;316:1009-1014.
DOI
ScienceOn
|
30 |
Matsuoka T, Hirata M, Tanaka H, et al. Prostaglandin D2 as a mediator of allergic asthma. Science 2000;287:2013-2017.
DOI
ScienceOn
|
31 |
Arimura A, Yasui K, Kishino J, et al. Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751. J Pharmacol Exp Ther 2001;298:411-419.
|
32 |
Zhu G, Vestbo J, Lenney W, et al. Association of PTGDR gene polymorphisms with asthma in two Caucasian populations. Genes Immun 2007;8:398-403.
DOI
ScienceOn
|
33 |
Cosmi L, Annunziato F, Iwasaki M, et al. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur J Immunol 2000;30:2972-2979.
DOI
ScienceOn
|
34 |
Monneret G, Li H, Vasilescu J, Rokach J, Powell WS. 15-Deoxydelta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. J Immunol 2002;168:3563-3569.
DOI
|
35 |
Nagata K, Hirai H, Tanaka K, et al. CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett 1999;459:195-199.
DOI
ScienceOn
|
36 |
Gosset P, Bureau F, Angeli V, et al. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J Immunol 2003;170:4943-4952.
DOI
|
37 |
Gazi L, Gyles S, Rose J, et al. Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes. Prostaglandins Other Lipid Mediat 2005;75:153-167.
DOI
ScienceOn
|
38 |
Heinemann A, Schuligoi R, Sabroe I, Hartnell A, Peskar BA. Delta 12-prostaglandin J2, a plasma metabolite of prostaglandin D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis. J Immunol 2003;170:4752-4758.
DOI
|
39 |
Schmidt G, Goehring UM, Schirmer J, et al. Lysine and polyamines are substrates for transglutamination of Rho by the Bordetella dermonecrotic toxin. Infect Immun 2001;69:7663-7670.
DOI
ScienceOn
|
40 |
Bohm E, Sturm GJ, Weiglhofer I, et al. 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. J Biol Chem 2004;279:7663-7670.
DOI
|
41 |
Sugimoto H, Shichijo M, Iino T, et al. An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. J Pharmacol Exp Ther 2003;305:347-352.
DOI
ScienceOn
|
42 |
Nagai H, Takeda H, Yamaguchi S, Tanaka H, Matsuo A, Inagaki N. The effect of a thromboxane A2 receptor antagonist BAY-u-3405 on experimental allergic reactions. Prostaglandins 1995;50:75-87.
DOI
ScienceOn
|
43 |
Shichijo M, Sugimoto H, Nagao K, et al. Chemoattractant receptor- homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats. J Pharmacol Exp Ther 2003;307:518-525.
DOI
ScienceOn
|
44 |
Uller L, Mathiesen JM, Alenmyr L, et al. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation. Respir Res 2007;8:16-25.
DOI
ScienceOn
|
45 |
Narita S, Asakura K, Kataura A. Effects of thromboxane A2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs. Int Arch Allergy Immunol 1996;109:161-166.
DOI
ScienceOn
|
46 |
Kabashima K, Narumiya S. The DP receptor, allergic inflammation and asthma. Prostaglandins Leukot Essent Fatty Acids 2003;69:187-194.
DOI
ScienceOn
|
47 |
Nagata K, Hirai H. The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. Prostaglandins Leukot Essent Fatty Acids 2003;69:169-177.
DOI
ScienceOn
|
48 |
Nantel F, Fong C, Lamontagne S, et al. Expression of prostaglandin D synthase and the prostaglandin D2 receptors DP and CRTH2 in human nasal mucosa. Prostaglandins Other Lipid Mediat 2004;73:87-101.
DOI
ScienceOn
|
49 |
Gallant MA, Samadfam R, Hackett JA, Antoniou J, Parent JL, de Brum-Fernandes AJ. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors. J Bone Miner Res 2005;20:672-681.
|
50 |
Hirai H, Abe H, Tanaka K, et al. Gene structure and functional properties of mouse CRTH2, a prostaglandin D2 receptor. Biochem Biophys Res Commun 2003;307:797-802.
DOI
ScienceOn
|
51 |
Xue L, Gyles SL, Wettey FR, et al. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol 2005;175:6531-6536.
DOI
|
52 |
Clarke DL, Belvisi MG, Smith SJ, et al. Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol 2005;288:L238-L250.
DOI
|
53 |
Venet F, Lepape A, Debard AL, Bienvenu J, Bohé J, Monneret G. The Th2 response as monitored by CRTH2 or CCR3 expression is severely decreased during septic shock. Clin Immunol 2004;113:278-284.
DOI
ScienceOn
|
54 |
Hamada K, Yamada Y, Kamada Y, et al. Prostaglandin D2 and interleukin-5 reduce CRTH2 surface expression on human eosinophils. Allergol Int 2004;53:179-184.
DOI
ScienceOn
|
55 |
Hammad H, Kool M, Soullié T, et al. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med 2007;204:357-367.
DOI
ScienceOn
|
56 |
Trivedi SG, Newson J, Rajakariar R, et al. Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity. Proc Natl Acad Sci U S A 2006;103:5179-5184.
DOI
ScienceOn
|
57 |
Shimura C, Satoh T, Igawa K, et al. Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin. Am J Pathol 2010;176:227-237.
DOI
ScienceOn
|
58 |
Gyles SL, Xue L, Townsend ER, Wettey F, Pettipher R. A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants. Immunology 2006;119:362-368.
DOI
ScienceOn
|
59 |
Wang YH, Ito T, Wang YH, et al. Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin- activated dendritic cells. Immunity 2006;24:827-838.
DOI
ScienceOn
|
60 |
Vinall SL, Townsend ER, Pettipher R. A paracrine role for chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2) in mediating chemotactic activation of CRTH2+ CD4+ T helper type 2 lymphocytes. Immunology 2007;121:577-584.
DOI
ScienceOn
|
61 |
Abe H, Takeshita T, Nagata K, et al. Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family. Gene 1999;227:71-77.
DOI
ScienceOn
|
62 |
Chevalier E, Stock J, Fisher T, et al. Cutting edge: chemoattractant receptor-homologous molecule expressed on Th2 cells plays a restricting role on IL-5 production and eosinophil recruitment. J Immunol 2005;175:2056-2060.
DOI
|
63 |
Satoh T, Moroi R, Aritake K, et al. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol 2006;177:2621-2629.
DOI
|
64 |
Holgate ST. The inflammation-repair cycle in asthma: the pivotal role of the airway epithelium. Clin Exp Allergy 1998;28 Suppl 5:97-103.
|
65 |
Chiba T, Kanda A, Ueki S, et al. Prostaglandin D2 induces IL-8 and GM-CSF by bronchial epithelial cells in a CRTH2-independent pathway. Int Arch Allergy Immunol 2006;141:300-307.
DOI
ScienceOn
|
66 |
Chan CL, Jones RL, Lau HY. Characterization of prostanoid receptors mediating inhibition of histamine release from anti- IgE-activated rat peritoneal mast cells. Br J Pharmacol 2000;129:589-597.
DOI
ScienceOn
|
67 |
Mesquita-Santos FP, Vieira-de-Abreu A, Calheiros AS, et al. Cutting edge: prostaglandin D2 enhances leukotriene C4 synthesis by eosinophils during allergic inflammation: synergistic in vivo role of endogenous eotaxin. J Immunol 2006;176:1326-1330.
DOI
|
68 |
Monneret G, Boumiza R, Gravel S, et al. Effects of prostaglandin D(2) and 5-lipoxygenase products on the expression of CD203c and CD11b by basophils. J Pharmacol Exp Ther 2005;312:627-634.
|
69 |
Okada N, Fukagawa K, Tanaka M, et al. CRTH2 expression on eosinophils from atopic patients. Invest Ophthalmol Vis Sci 2004;45:4853-B177.
|
70 |
Huang JL, Gao PS, Mathias RA, et al. Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability. Hum Mol Genet 2004;13:2691-2697.
DOI
ScienceOn
|
71 |
Luster AD, Tager AM. T-cell trafficking in asthma: lipid mediators grease the way. Nat Rev Immunol 2004;4:711-724
DOI
ScienceOn
|
72 |
Hata AN, Breyer RM. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 2004;103:147-166.
DOI
ScienceOn
|
73 |
Oguma T, Palmer LJ, Birben E, Sonna LA, Asano K, Lilly CM. Role of prostanoid DP receptor variants in susceptibility to asthma. N Engl J Med 2004;351:1752-1763.
DOI
ScienceOn
|